| __timestamp | Supernus Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 19586000 | 55430000 |
| Thursday, January 1, 2015 | 29135000 | 65510000 |
| Friday, January 1, 2016 | 42791000 | 71160000 |
| Sunday, January 1, 2017 | 49577000 | 70644000 |
| Monday, January 1, 2018 | 89209000 | 70418000 |
| Tuesday, January 1, 2019 | 69099000 | 63238000 |
| Wednesday, January 1, 2020 | 75961000 | 59777000 |
| Friday, January 1, 2021 | 90467000 | 60152000 |
| Saturday, January 1, 2022 | 74552000 | 54540000 |
| Sunday, January 1, 2023 | 91593000 | 52243000 |
| Monday, January 1, 2024 | 64536000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Supernus Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Supernus Pharmaceuticals increased its R&D expenses by nearly 368%, peaking in 2023 with a 91.6 million USD investment. This aggressive strategy underscores their commitment to pioneering new treatments. In contrast, Taro Pharmaceutical's R&D spending remained relatively stable, with a modest 16% decrease over the same period, reflecting a more conservative approach. Notably, Taro's R&D expenses in 2023 were 52.2 million USD, highlighting a potential strategic pivot. As the pharmaceutical landscape evolves, these spending patterns may significantly influence each company's market position and innovation pipeline.
Research and Development Expenses Breakdown: GSK plc vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Bio-Techne Corporation vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: TG Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: MorphoSys AG and Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Bausch Health Companies Inc. vs Supernus Pharmaceuticals, Inc.
R&D Insights: How Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds
Supernus Pharmaceuticals, Inc. vs Mesoblast Limited: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Supernus Pharmaceuticals, Inc. and Evotec SE
Comparing Innovation Spending: Supernus Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Geron Corporation or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Taro Pharmaceutical Industries Ltd. vs Evotec SE: Strategic Focus on R&D Spending